Redhill Biopharma
RDHL
#10410
Rank
C$7.8 M
Marketcap
C$1.53
Share price
-2.61%
Change (1 day)
-81.99%
Change (1 year)

EPS for Redhill Biopharma (RDHL)

EPS in 2023 (TTM): C-$907.70

According to Redhill Biopharma's latest financial reports the company's current EPS (TTM) is C-$954.32. In 2017 the company made an earnings per share (EPS) of C-$3,408 a decrease over its 2016 EPS that were of C-$2,999.

EPS history for Redhill Biopharma from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)C-$907.70
2017C-$3,40813.64%
2016C-$2,9999.12%
2015C-$2,74968.01%
2014C-$1,636-25.93%
2013C-$2,209

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
C$5.05-100.53%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$10.35-101.08%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$4.90-100.51%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
C$0.86-100.09%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
C$1.66-100.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel